发明名称 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents
摘要 A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs. topoisomerase I. The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline. Two of the most potent topoisomerase I inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2,3-dimethoxy-8,9-(methylenedioxy)11H-indeno[1,2-c]isoquinolinium chloride (27). Two additional potent topoisomerase I inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect topoisomerase II.
申请公布号 EP2050452(A1) 申请公布日期 2009.04.22
申请号 EP20090000858 申请日期 1999.10.14
申请人 PURDUE RESEARCH FOUNDATION;THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 CUSHMAN, MARK S.;JAYARAMAN, MUTHUSAMY;NAGAFUJI, PAMELA M.;POMMIER, YVES G.
分类号 A61K31/473;A61K31/47;A61K31/472;A61K31/4741;A61P35/00;C07D217/24;C07D217/26;C07D221/18;C07D491/056;C07D491/22 主分类号 A61K31/473
代理机构 代理人
主权项
地址